CELLULAR / SINGLE
SS-31
10MG · 50MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A mitochondria-targeted peptide studied for its interaction with cardiolipin in the inner mitochondrial membrane.
Available Strengths
- 10MG (2S10)
- 50MG (2S50)
Research Protocol
Reference standard schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–2 | 5 mg | 50 | 0.5 mL |
| Weeks 3–8 | 10 mg | 100 | 1 mL |
Reconstitution
10 mg/mL once reconstituted
- Draw 1.0 mL of bacteriostatic water per 10 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Described as selectively binding cardiolipin, stabilising electron-transport-chain complexes, reducing reactive-oxygen-species production and supporting ATP synthesis in the cited research.
Storage
−20°C, cited as stable for months when frozen. 2–8°C, use within 4 weeks, avoid freeze-thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source